Literature DB >> 11525644

Endogenous IL-1 and type II IL-1 receptor expression modulate anoikis in intestinal epithelial cells.

C C Waterhouse1, R R Joseph, A W Stadnyk.   

Abstract

We previously reported that IL-1beta and the decoy receptor for IL-1 (IL-1RII) are expressed by intestinal epithelial cells (IEC) during detachment-induced cell death, or "anoikis." We now investigated whether IL-1 regulates anoikis. Skewing the balance in favor of IL-1, by blocking IL-1RII or by adding IL-1beta to detached rat IEC-18 cells, reduced cell death. The protective effect of anti-IL-1RII was reversed by blocking IL-1beta, confirming the anti-apoptotic effect was due to endogenous IL-1beta. Added IL-1beta also rescued cells from anoikis and was associated with considerable aggregation of the detached cells. Aggregate formation and the anti-apoptotic effect of added IL-1beta were prevented by blocking E-cadherin, indicating that IL-1 promoted aggregation and indirectly, survival. On the other hand, treating detached cells with IL-1beta and an anti-beta(1) integrin antibody abolished the protective effect of IL-1beta but not the aggregates. We conclude that the anti-apoptotic effect of IL-1 is mediated through a beta(1) integrin-dependent event secondary to cell-cell adhesion. This illustrates a previously uncharacterized role for IL-1 in the intestine wherein this cytokine may facilitate the preservation of the epithelial monolayer integrity. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525644     DOI: 10.1006/excr.2001.5303

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells.

Authors:  Sen Rong Yan; Robbie Randle Joseph; Kirill Rosen; Mauricio J Reginato; Amanda Jackson; Norman Allaire; Joan S Brugge; Christian Jobin; Andrew W Stadnyk
Journal:  Oncogene       Date:  2005-09-29       Impact factor: 9.867

Review 2.  Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Thao T B Ho; Benjamin A Torres; Robin K Ohls; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2016-11-07       Impact factor: 3.300

3.  Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

Authors:  Marina K Roell; Hassan Issafras; Robert J Bauer; Kristen S Michelson; Nerissa Mendoza; Sandra I Vanegas; Lisa M Gross; Paul D Larsen; Daniel H Bedinger; David J Bohmann; Genevieve H Nonet; Naichi Liu; Steve R Lee; Masahisa Handa; Seema S Kantak; Arnold H Horwitz; John J Hunter; Alexander M Owyang; Amer M Mirza; John A Corbin; Mark L White
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

4.  Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist.

Authors:  Andrew W Stadnyk; Moorix M W Yeung; Sen Rong Yan
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

5.  Short-term exposure to urban PM2.5 particles induces histopathological and inflammatory changes in the rat small intestine.

Authors:  Lena Ohlsson; Christina Isaxon; Sebastian Wrighton; Wissal El Ouahidi; Lisa Fornell; Lena Uller; Saema Ansar; Ulrikke Voss
Journal:  Physiol Rep       Date:  2022-04

6.  Trinitrobenzene sulfonic acid-induced intestinal injury in neonatal mice activates transcriptional networks similar to those seen in human necrotizing enterocolitis.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Feng Cheng; Rays H Y Jiang; Jaime Flores-Torres; Benjamin A Torres; Akhil Maheshwari
Journal:  Pediatr Res       Date:  2016-09-22       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.